Loading…
Tricyclic xanthine derivatives containing a basic substituent: adenosine receptor affinity and drug-related properties
A library of 27 novel amide derivatives of annelated xanthines was designed and synthesized. The new compounds represent 1,3-dipropyl- and 1,3-dibutyl-pyrimido[2,1- ]purinedione-9-ethylphenoxy derivatives including a CH CONH linker between the (CH ) -amino group and the phenoxy moiety. A synthetic s...
Saved in:
Published in: | MedChemComm 2018-06, Vol.9 (6), p.951-962 |
---|---|
Main Authors: | , , , , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c351t-44e2314f3cf672b90f13fcb41cef77057e009b923a6333e46f2cc24929311a7e3 |
---|---|
cites | cdi_FETCH-LOGICAL-c351t-44e2314f3cf672b90f13fcb41cef77057e009b923a6333e46f2cc24929311a7e3 |
container_end_page | 962 |
container_issue | 6 |
container_start_page | 951 |
container_title | MedChemComm |
container_volume | 9 |
creator | Załuski, Michał Stanuch, Katarzyna Karcz, Tadeusz Hinz, Sonja Latacz, Gniewomir Szymańska, Ewa Schabikowski, Jakub Doroż-Płonka, Agata Handzlik, Jadwiga Drabczyńska, Anna Müller, Christa E Kieć-Kononowicz, Katarzyna |
description | A library of 27 novel amide derivatives of annelated xanthines was designed and synthesized. The new compounds represent 1,3-dipropyl- and 1,3-dibutyl-pyrimido[2,1-
]purinedione-9-ethylphenoxy derivatives including a CH
CONH linker between the (CH
)
-amino group and the phenoxy moiety. A synthetic strategy to obtain the final products was developed involving solvent-free microwave irradiation. The new compounds were evaluated for their adenosine receptor (AR) affinities. The most potent derivatives contained a terminal tertiary amino function. Compounds with nanomolar AR affinities and at the same time high water-solubility were obtained (A
(
= 24-605 nM), A
(
= 242-1250 nM), A
(
= 66-911 nM) and A
(
= 155-1000 nM)). 2-(4-(2-(1,3-Dibutyl-2,4-dioxo-1,2,3,4,7,8-hexahydropyrimido[2,1-
]purin-9(6
)-yl)ethyl)phenoxy)-
-(3-(diethylamino)propyl)acetamide (
) and the corresponding
-(2-(pyrrolidin-1-yl)ethyl)acetamide (
) were found to be the most potent antagonists of the present series. While
showed CYP inhibition and moderate metabolic stability,
was found to possess suitable properties for
applications. In an attempt to explain the affinity data for the synthesized compounds, molecular modeling and docking studies were performed using homology models of A
and A
adenosine receptors. The potent compound
was used as an example for discussion of the possible ligand-protein interactions. Moreover, the compounds showed high water-solubility indicating that the approach of introducing a basic side chain was successful for the class of generally poorly soluble AR antagonists. |
doi_str_mv | 10.1039/c8md00070k |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2088758257</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2088758257</sourcerecordid><originalsourceid>FETCH-LOGICAL-c351t-44e2314f3cf672b90f13fcb41cef77057e009b923a6333e46f2cc24929311a7e3</originalsourceid><addsrcrecordid>eNpd0UtPGzEQAGCrKioRcOEHIEu9VEhLx4-Nvb1VoUBVEBc4r7zeMRg23tT2Rs2_ryFpDj3NHL55aIaQUwYXDETz1eplDwAKXj-QGQcJFa8Z-7jPQRySk5ReigHBtW7kJ3IogIFutJyR9UP0dmMHb-kfE_KzD0h7jH5tsl9jonYM2fjgwxM1tDOpuDR1Kfs8YcjfqOkxjOmtKqLFVR4jNc6VgryhJvS0j9NTFXEwGXu6iuMKY_aYjsmBM0PCk108Io9XPx4WN9Xt_fXPxffbyoqa5UpK5IJJJ6ybK9414JhwtpPMolMKaoUATddwYeZCCJRzx63lsuGNYMwoFEfky7ZvGf17wpTbpU8Wh8EEHKfUctBa1ZrXqtDP_9GXcYqhbFdUrcolQbKizrfKxjGliK5dRb80cdMyaN8e0i703eX7Q34VfLZrOXVL7Pf03_nFX0qvhrM</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2057250041</pqid></control><display><type>article</type><title>Tricyclic xanthine derivatives containing a basic substituent: adenosine receptor affinity and drug-related properties</title><source>PubMed Central</source><source>Royal Society of Chemistry</source><creator>Załuski, Michał ; Stanuch, Katarzyna ; Karcz, Tadeusz ; Hinz, Sonja ; Latacz, Gniewomir ; Szymańska, Ewa ; Schabikowski, Jakub ; Doroż-Płonka, Agata ; Handzlik, Jadwiga ; Drabczyńska, Anna ; Müller, Christa E ; Kieć-Kononowicz, Katarzyna</creator><creatorcontrib>Załuski, Michał ; Stanuch, Katarzyna ; Karcz, Tadeusz ; Hinz, Sonja ; Latacz, Gniewomir ; Szymańska, Ewa ; Schabikowski, Jakub ; Doroż-Płonka, Agata ; Handzlik, Jadwiga ; Drabczyńska, Anna ; Müller, Christa E ; Kieć-Kononowicz, Katarzyna</creatorcontrib><description>A library of 27 novel amide derivatives of annelated xanthines was designed and synthesized. The new compounds represent 1,3-dipropyl- and 1,3-dibutyl-pyrimido[2,1-
]purinedione-9-ethylphenoxy derivatives including a CH
CONH linker between the (CH
)
-amino group and the phenoxy moiety. A synthetic strategy to obtain the final products was developed involving solvent-free microwave irradiation. The new compounds were evaluated for their adenosine receptor (AR) affinities. The most potent derivatives contained a terminal tertiary amino function. Compounds with nanomolar AR affinities and at the same time high water-solubility were obtained (A
(
= 24-605 nM), A
(
= 242-1250 nM), A
(
= 66-911 nM) and A
(
= 155-1000 nM)). 2-(4-(2-(1,3-Dibutyl-2,4-dioxo-1,2,3,4,7,8-hexahydropyrimido[2,1-
]purin-9(6
)-yl)ethyl)phenoxy)-
-(3-(diethylamino)propyl)acetamide (
) and the corresponding
-(2-(pyrrolidin-1-yl)ethyl)acetamide (
) were found to be the most potent antagonists of the present series. While
showed CYP inhibition and moderate metabolic stability,
was found to possess suitable properties for
applications. In an attempt to explain the affinity data for the synthesized compounds, molecular modeling and docking studies were performed using homology models of A
and A
adenosine receptors. The potent compound
was used as an example for discussion of the possible ligand-protein interactions. Moreover, the compounds showed high water-solubility indicating that the approach of introducing a basic side chain was successful for the class of generally poorly soluble AR antagonists.</description><identifier>ISSN: 2040-2503</identifier><identifier>EISSN: 2040-2511</identifier><identifier>DOI: 10.1039/c8md00070k</identifier><identifier>PMID: 30108984</identifier><language>eng</language><publisher>England: Royal Society of Chemistry</publisher><subject>Adenosine ; Affinity ; Antagonists ; Chemical synthesis ; Derivatives ; Docking ; Homology ; Irradiation ; Molecular chains ; Molecular modelling ; Protein interaction ; Proteins ; Receptors ; Solubility ; Xanthines</subject><ispartof>MedChemComm, 2018-06, Vol.9 (6), p.951-962</ispartof><rights>Copyright Royal Society of Chemistry 2018</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c351t-44e2314f3cf672b90f13fcb41cef77057e009b923a6333e46f2cc24929311a7e3</citedby><cites>FETCH-LOGICAL-c351t-44e2314f3cf672b90f13fcb41cef77057e009b923a6333e46f2cc24929311a7e3</cites><orcidid>0000-0003-3025-7002 ; 0000-0002-6752-7443 ; 0000-0002-0013-6624</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/30108984$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Załuski, Michał</creatorcontrib><creatorcontrib>Stanuch, Katarzyna</creatorcontrib><creatorcontrib>Karcz, Tadeusz</creatorcontrib><creatorcontrib>Hinz, Sonja</creatorcontrib><creatorcontrib>Latacz, Gniewomir</creatorcontrib><creatorcontrib>Szymańska, Ewa</creatorcontrib><creatorcontrib>Schabikowski, Jakub</creatorcontrib><creatorcontrib>Doroż-Płonka, Agata</creatorcontrib><creatorcontrib>Handzlik, Jadwiga</creatorcontrib><creatorcontrib>Drabczyńska, Anna</creatorcontrib><creatorcontrib>Müller, Christa E</creatorcontrib><creatorcontrib>Kieć-Kononowicz, Katarzyna</creatorcontrib><title>Tricyclic xanthine derivatives containing a basic substituent: adenosine receptor affinity and drug-related properties</title><title>MedChemComm</title><addtitle>Medchemcomm</addtitle><description>A library of 27 novel amide derivatives of annelated xanthines was designed and synthesized. The new compounds represent 1,3-dipropyl- and 1,3-dibutyl-pyrimido[2,1-
]purinedione-9-ethylphenoxy derivatives including a CH
CONH linker between the (CH
)
-amino group and the phenoxy moiety. A synthetic strategy to obtain the final products was developed involving solvent-free microwave irradiation. The new compounds were evaluated for their adenosine receptor (AR) affinities. The most potent derivatives contained a terminal tertiary amino function. Compounds with nanomolar AR affinities and at the same time high water-solubility were obtained (A
(
= 24-605 nM), A
(
= 242-1250 nM), A
(
= 66-911 nM) and A
(
= 155-1000 nM)). 2-(4-(2-(1,3-Dibutyl-2,4-dioxo-1,2,3,4,7,8-hexahydropyrimido[2,1-
]purin-9(6
)-yl)ethyl)phenoxy)-
-(3-(diethylamino)propyl)acetamide (
) and the corresponding
-(2-(pyrrolidin-1-yl)ethyl)acetamide (
) were found to be the most potent antagonists of the present series. While
showed CYP inhibition and moderate metabolic stability,
was found to possess suitable properties for
applications. In an attempt to explain the affinity data for the synthesized compounds, molecular modeling and docking studies were performed using homology models of A
and A
adenosine receptors. The potent compound
was used as an example for discussion of the possible ligand-protein interactions. Moreover, the compounds showed high water-solubility indicating that the approach of introducing a basic side chain was successful for the class of generally poorly soluble AR antagonists.</description><subject>Adenosine</subject><subject>Affinity</subject><subject>Antagonists</subject><subject>Chemical synthesis</subject><subject>Derivatives</subject><subject>Docking</subject><subject>Homology</subject><subject>Irradiation</subject><subject>Molecular chains</subject><subject>Molecular modelling</subject><subject>Protein interaction</subject><subject>Proteins</subject><subject>Receptors</subject><subject>Solubility</subject><subject>Xanthines</subject><issn>2040-2503</issn><issn>2040-2511</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><recordid>eNpd0UtPGzEQAGCrKioRcOEHIEu9VEhLx4-Nvb1VoUBVEBc4r7zeMRg23tT2Rs2_ryFpDj3NHL55aIaQUwYXDETz1eplDwAKXj-QGQcJFa8Z-7jPQRySk5ReigHBtW7kJ3IogIFutJyR9UP0dmMHb-kfE_KzD0h7jH5tsl9jonYM2fjgwxM1tDOpuDR1Kfs8YcjfqOkxjOmtKqLFVR4jNc6VgryhJvS0j9NTFXEwGXu6iuMKY_aYjsmBM0PCk108Io9XPx4WN9Xt_fXPxffbyoqa5UpK5IJJJ6ybK9414JhwtpPMolMKaoUATddwYeZCCJRzx63lsuGNYMwoFEfky7ZvGf17wpTbpU8Wh8EEHKfUctBa1ZrXqtDP_9GXcYqhbFdUrcolQbKizrfKxjGliK5dRb80cdMyaN8e0i703eX7Q34VfLZrOXVL7Pf03_nFX0qvhrM</recordid><startdate>20180601</startdate><enddate>20180601</enddate><creator>Załuski, Michał</creator><creator>Stanuch, Katarzyna</creator><creator>Karcz, Tadeusz</creator><creator>Hinz, Sonja</creator><creator>Latacz, Gniewomir</creator><creator>Szymańska, Ewa</creator><creator>Schabikowski, Jakub</creator><creator>Doroż-Płonka, Agata</creator><creator>Handzlik, Jadwiga</creator><creator>Drabczyńska, Anna</creator><creator>Müller, Christa E</creator><creator>Kieć-Kononowicz, Katarzyna</creator><general>Royal Society of Chemistry</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QL</scope><scope>7QO</scope><scope>7T5</scope><scope>7T7</scope><scope>7TO</scope><scope>7U7</scope><scope>7U9</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>H94</scope><scope>M7N</scope><scope>P64</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0003-3025-7002</orcidid><orcidid>https://orcid.org/0000-0002-6752-7443</orcidid><orcidid>https://orcid.org/0000-0002-0013-6624</orcidid></search><sort><creationdate>20180601</creationdate><title>Tricyclic xanthine derivatives containing a basic substituent: adenosine receptor affinity and drug-related properties</title><author>Załuski, Michał ; Stanuch, Katarzyna ; Karcz, Tadeusz ; Hinz, Sonja ; Latacz, Gniewomir ; Szymańska, Ewa ; Schabikowski, Jakub ; Doroż-Płonka, Agata ; Handzlik, Jadwiga ; Drabczyńska, Anna ; Müller, Christa E ; Kieć-Kononowicz, Katarzyna</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c351t-44e2314f3cf672b90f13fcb41cef77057e009b923a6333e46f2cc24929311a7e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Adenosine</topic><topic>Affinity</topic><topic>Antagonists</topic><topic>Chemical synthesis</topic><topic>Derivatives</topic><topic>Docking</topic><topic>Homology</topic><topic>Irradiation</topic><topic>Molecular chains</topic><topic>Molecular modelling</topic><topic>Protein interaction</topic><topic>Proteins</topic><topic>Receptors</topic><topic>Solubility</topic><topic>Xanthines</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Załuski, Michał</creatorcontrib><creatorcontrib>Stanuch, Katarzyna</creatorcontrib><creatorcontrib>Karcz, Tadeusz</creatorcontrib><creatorcontrib>Hinz, Sonja</creatorcontrib><creatorcontrib>Latacz, Gniewomir</creatorcontrib><creatorcontrib>Szymańska, Ewa</creatorcontrib><creatorcontrib>Schabikowski, Jakub</creatorcontrib><creatorcontrib>Doroż-Płonka, Agata</creatorcontrib><creatorcontrib>Handzlik, Jadwiga</creatorcontrib><creatorcontrib>Drabczyńska, Anna</creatorcontrib><creatorcontrib>Müller, Christa E</creatorcontrib><creatorcontrib>Kieć-Kononowicz, Katarzyna</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Biotechnology Research Abstracts</collection><collection>Immunology Abstracts</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>MedChemComm</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Załuski, Michał</au><au>Stanuch, Katarzyna</au><au>Karcz, Tadeusz</au><au>Hinz, Sonja</au><au>Latacz, Gniewomir</au><au>Szymańska, Ewa</au><au>Schabikowski, Jakub</au><au>Doroż-Płonka, Agata</au><au>Handzlik, Jadwiga</au><au>Drabczyńska, Anna</au><au>Müller, Christa E</au><au>Kieć-Kononowicz, Katarzyna</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Tricyclic xanthine derivatives containing a basic substituent: adenosine receptor affinity and drug-related properties</atitle><jtitle>MedChemComm</jtitle><addtitle>Medchemcomm</addtitle><date>2018-06-01</date><risdate>2018</risdate><volume>9</volume><issue>6</issue><spage>951</spage><epage>962</epage><pages>951-962</pages><issn>2040-2503</issn><eissn>2040-2511</eissn><abstract>A library of 27 novel amide derivatives of annelated xanthines was designed and synthesized. The new compounds represent 1,3-dipropyl- and 1,3-dibutyl-pyrimido[2,1-
]purinedione-9-ethylphenoxy derivatives including a CH
CONH linker between the (CH
)
-amino group and the phenoxy moiety. A synthetic strategy to obtain the final products was developed involving solvent-free microwave irradiation. The new compounds were evaluated for their adenosine receptor (AR) affinities. The most potent derivatives contained a terminal tertiary amino function. Compounds with nanomolar AR affinities and at the same time high water-solubility were obtained (A
(
= 24-605 nM), A
(
= 242-1250 nM), A
(
= 66-911 nM) and A
(
= 155-1000 nM)). 2-(4-(2-(1,3-Dibutyl-2,4-dioxo-1,2,3,4,7,8-hexahydropyrimido[2,1-
]purin-9(6
)-yl)ethyl)phenoxy)-
-(3-(diethylamino)propyl)acetamide (
) and the corresponding
-(2-(pyrrolidin-1-yl)ethyl)acetamide (
) were found to be the most potent antagonists of the present series. While
showed CYP inhibition and moderate metabolic stability,
was found to possess suitable properties for
applications. In an attempt to explain the affinity data for the synthesized compounds, molecular modeling and docking studies were performed using homology models of A
and A
adenosine receptors. The potent compound
was used as an example for discussion of the possible ligand-protein interactions. Moreover, the compounds showed high water-solubility indicating that the approach of introducing a basic side chain was successful for the class of generally poorly soluble AR antagonists.</abstract><cop>England</cop><pub>Royal Society of Chemistry</pub><pmid>30108984</pmid><doi>10.1039/c8md00070k</doi><tpages>12</tpages><orcidid>https://orcid.org/0000-0003-3025-7002</orcidid><orcidid>https://orcid.org/0000-0002-6752-7443</orcidid><orcidid>https://orcid.org/0000-0002-0013-6624</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 2040-2503 |
ispartof | MedChemComm, 2018-06, Vol.9 (6), p.951-962 |
issn | 2040-2503 2040-2511 |
language | eng |
recordid | cdi_proquest_miscellaneous_2088758257 |
source | PubMed Central; Royal Society of Chemistry |
subjects | Adenosine Affinity Antagonists Chemical synthesis Derivatives Docking Homology Irradiation Molecular chains Molecular modelling Protein interaction Proteins Receptors Solubility Xanthines |
title | Tricyclic xanthine derivatives containing a basic substituent: adenosine receptor affinity and drug-related properties |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-26T19%3A21%3A19IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Tricyclic%20xanthine%20derivatives%20containing%20a%20basic%20substituent:%20adenosine%20receptor%20affinity%20and%20drug-related%20properties&rft.jtitle=MedChemComm&rft.au=Za%C5%82uski,%20Micha%C5%82&rft.date=2018-06-01&rft.volume=9&rft.issue=6&rft.spage=951&rft.epage=962&rft.pages=951-962&rft.issn=2040-2503&rft.eissn=2040-2511&rft_id=info:doi/10.1039/c8md00070k&rft_dat=%3Cproquest_cross%3E2088758257%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c351t-44e2314f3cf672b90f13fcb41cef77057e009b923a6333e46f2cc24929311a7e3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2057250041&rft_id=info:pmid/30108984&rfr_iscdi=true |